神经肽 FF 受体 (NPFFR) 是一类属于 RF 酰胺受体亚家族的 G 蛋白偶联受体 (GPCR),特异性结合神经肽 FF (NPFF) 及其类似肽 (如 NPAF、NPSF)。
NPFFR 具有两种亚型:NPFFR1 (GPR147) 和 NPFFR2 (GPR74),这些受体可调节多种生理功能,包括调节疼痛、阿片副作用、摄食、药物奖赏、焦虑、心脏功能以及控制胰岛素释放等。
基于其多效性功能,NPFFR 被视为治疗慢性疼痛、阿片依赖、代谢性疾病(如肥胖)及焦虑障碍的潜力靶点[1][2]。
Neuropeptide FF Receptor (NPFFR) is a type of G Protein-Coupled Receptor (GPCR) belonging to the RFamide receptor subfamily, specifically binding to neuropeptide FF (NPFF) and its analogous peptides (such as NPAF, NPSF).
NPFFR has two subtypes: NPFFR1 (GPR147) and NPFFR2 (GPR74), and these receptors regulate a variety of physiological functions, including modulation of pain, opioid side effects, feeding, drug reward, anxiety, cardiac function, and control of insulin release, among others.
Based on its pleiotropic functions, NPFFR is considered a potential target for the treatment of chronic pain, opioid dependence, metabolic diseases (such as obesity), and anxiety disorders[1][2].
RFRP-3 (mouse) 是禽类促性腺激素抑制激素 (GnIH) 的功能同源物,可与 GPR147 结合,通过抑制 FSHR 及参与类固醇生成的关键酶 (P450scc、3β-HSD、StAR) 减少 Progesterone 的合成,诱导细胞凋亡 (Apoptosis)(伴随 p53 增加),并抑制 ERK 信号通路,因此可用于卵泡发育研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号